Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market.
NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
March 18, 2019
Fervent Pharmaceuticals, a clinical-stage drug development company based in Greenville, has announced positive results from its Phase 2A clinical trial of FP-101, a non-hormonal, non-herbal, non-antidepressant treatment of the vasomotor symptoms that accompany menopause.
March 15, 2019
Cary-based agricultural technology company Verdesian Life Sciences' global workforce of 225 strives to advance the company’s goal “to enable a sustainable future for farmers through nutrient use efficiency.”
March 14, 2019
Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
March 12, 2019
Norman E. “Ned” Sharpless, M.D., who is currently director of the National Cancer Institute, was named acting commissioner Tuesday to replace FDA Commissioner Scott Gottlieb, M.D. Gottlieb unexpectedly announced his resignation March 5.
March 8, 2019
North Carolina’s Research Triangle region is among the nation’s largest and fastest-growing markets in the life sciences, according to a new report by Los Angeles-based CBRE Group, the world’s largest commercial real estate services and investment firm.
March 8, 2019
To add momentum to the fast-growing field of precision medicine, Durham-based IQVIA has launched a patented new technology platform for life science customers to access big data needed for a wide range of research activities.
March 7, 2019
The Personalized Medicine Coalition promotes policies that support personalized medicine and encourages physicians to integrate personalized medicine in clinical settings.
March 7, 2019
Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.
March 5, 2019
Want to know what people think of Raleigh? Or Charlotte? Where to buy your next McMeal? Then check out Numbeo. It's saying Raleigh and Charlotte are among the best metros in the world for quality of life.
March 5, 2019
A north Raleigh drug-manufacturing site purchased in 2014 by Denmark-based Xellia Pharmaceuticals has been sold again -- this time to Sagent Pharmaceuticals of Schaumburg, Illinois.
March 5, 2019
Durham-based Precision BioSciences, a genome-editing company focused on creating better foods and medicines, wants to raise up to $100 million in an initial public offering (IPO) of stock.
March 1, 2019
Dignify Therapeutics, a virtual drug development company in Research Triangle Park, has received a $3.6 million federal grant to help develop its lead drug candidate for a future Phase 1 clinical study.
February 28, 2019
A panel of venture investment fund managers offered their insights into raising venture capital in the life sciences Wednesday during the 2019 CED Life Science Conference at the Raleigh Convention Center.
February 27, 2019
For any bioscience entrepreneurs in North Carolina who may be tempted to exaggerate claims about their products and technologies, investigative journalist John Carreyrou has some advice: do so at your own peril.